UCLA Department of Medicine-Hematology/Oncology — Los Angeles, California

UCLA Department of Medicine-Hematology/Oncology is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

UCLA Department of Medicine-Hematology/Oncology has participated in 29 clinical trials with 18 currently active.

Therapeutic areas: Breast Cancer, Gastrointestinal Tumors, Colorectal Adenocarcinomas.

Sponsors: Pfizer, Merck Sharp & Dohme LLC, Astellas Pharma Global Development, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Angeles

Browse all research sites in California · View every site in Los Angeles

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Department of Medicine-Hematology/Oncology?

UCLA Department of Medicine-Hematology/Oncology has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Department of Medicine-Hematology/Oncology conducted?

UCLA Department of Medicine-Hematology/Oncology has 29 clinical trials on record, with 18 currently active. Their work covers Breast Cancer, Gastrointestinal Tumors, Colorectal Adenocarcinomas.

Is UCLA Department of Medicine-Hematology/Oncology accredited by Crixeo Clinical Trials?

UCLA Department of Medicine-Hematology/Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Department of Medicine-Hematology/Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.